List of works - Hiroaki Ikesue

A Case of Acute Kidney Injury Associated With Dabrafenib and Trametinib Treatment for Metastatic Melanoma

scientific article published on 12 June 2018

A multi-institutional study analyzing effect of prophylactic medication for prevention of opioid-induced gastrointestinal dysfunction.

scientific article

Analysis of immune-related adverse events caused by immune checkpoint inhibitors using the Japanese Adverse Drug Event Report database

scientific article published on 01 September 2020

Analysis of the variable factors influencing tacrolimus blood concentration during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantation.

scientific article published on 7 November 2016

Antiemetic effectiveness and safety of aprepitant in patients with hematologic malignancy receiving multiday chemotherapy.

scientific article published in February 2013

Comparison of antiemetic effects of granisetron and palonosetron in patients receiving bendamustine-based chemotherapy

scientific article published on 01 May 2018

Cyclosporine enhances alpha1-adrenoceptor-mediated nitric oxide production in C6 glioma cells.

scientific article published in November 2000

Decrease in venous irritation by adjusting the concentration of injected bendamustine

scientific article published on 08 February 2013

Differences in recognition of similar medication names between pharmacists and nurses: a retrospective study

scientific article

Effect of the number of dose adjustment factors on bleeding risk in patients receiving 30 mg/day edoxaban

scientific article published on 11 October 2019

Effectiveness and safety of antiemetic aprepitant in Japanese patients receiving high-dose chemotherapy prior to autologous hematopoietic stem cell transplantation

scientific article published on 01 January 2013

Efficacy and safety of aprepitant in allogeneic hematopoietic stem cell transplantation

scientific article published on 26 May 2013

Evaluation of pharmaceutical intervention in direct-acting antiviral agents for hepatitis C virus infected patients in an ambulatory setting: a retrospective analysis

scientific article published on 17 July 2018

Evaluation of the usefulness of protocol-based pharmacist-facilitated laboratory monitoring to ensure the safety of immune checkpoint inhibitors in patients with lung cancer

scientific article published on 10 June 2020

Implementation of institutional antiemetic guidelines for low emetic risk chemotherapy with docetaxel: a clinical and cost evaluation.

scientific article published on 25 September 2011

Incidence and risk factors for paclitaxel hypersensitivity during ovarian cancer chemotherapy.

scientific article published on 25 March 2005

Increased Topical Tacrolimus Absorption in Generalized Leukemic Erythroderma ⬇️

scientific article published on October 1, 2003

Interaction between warfarin and short-term intravenous amiodarone in intensive care unit patients after cardiac surgery.

scientific article published on 30 May 2018

Involvement of spinal NR2B-containing NMDA receptors in oxaliplatin-induced mechanical allodynia in rats.

scientific article

Monitoring for potential adverse drug reactions in patients receiving chemotherapy.

scientific article

Ovariectomy aggravates hypersensitivity reactions to paclitaxel in rats

Population pharmacokinetics of tacrolimus in umbilical cord blood transplant patients focusing on the variation in red blood cell counts

scientific article published on 22 October 2020

Prevention of oxaliplatin‐induced mechanical allodynia and neurodegeneration by neurotropin in the rat model ⬇️

scientific article published on September 9, 2010

Risk Factors for Major Bleeding and Clinically Relevant Non-major Bleeding in Japanese Patients Treated with Edoxaban

scientific article published on 18 December 2019

Risk Factors for Predicting Severe Neutropenia Induced by Pemetrexed Plus Carboplatin Therapy in Patients with Advanced Non-small Cell Lung Cancer

scientific article published on January 2015

Risk factors for predicting severe neutropenia induced by amrubicin in patients with advanced lung cancer.

scientific article published in January 2012

Stability of cetuximab and panitumumab in glass vials and polyvinyl chloride bags.

scientific article

Switching from zoledronic acid to denosumab increases the risk for developing medication-related osteonecrosis of the jaw in patients with bone metastases

scientific article published in 2021

Time Course of Calcium Concentrations and Risk Factors for Hypocalcemia in Patients Receiving Denosumab for the Treatment of Bone Metastases From Cancer

scientific article published on 13 June 2014

List of works by Hiroaki Ikesue

A Case of Acute Kidney Injury Associated With Dabrafenib and Trametinib Treatment for Metastatic Melanoma

A multi-institutional study analyzing effect of prophylactic medication for prevention of opioid-induced gastrointestinal dysfunction.

Analysis of immune-related adverse events caused by immune checkpoint inhibitors using the Japanese Adverse Drug Event Report database

Analysis of the variable factors influencing tacrolimus blood concentration during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantation.

Antiemetic effectiveness and safety of aprepitant in patients with hematologic malignancy receiving multiday chemotherapy.

Comparison of antiemetic effects of granisetron and palonosetron in patients receiving bendamustine-based chemotherapy

Cyclosporine enhances alpha1-adrenoceptor-mediated nitric oxide production in C6 glioma cells.

Decrease in venous irritation by adjusting the concentration of injected bendamustine

Differences in recognition of similar medication names between pharmacists and nurses: a retrospective study

Effect of the number of dose adjustment factors on bleeding risk in patients receiving 30 mg/day edoxaban

Effectiveness and safety of antiemetic aprepitant in Japanese patients receiving high-dose chemotherapy prior to autologous hematopoietic stem cell transplantation

Efficacy and safety of aprepitant in allogeneic hematopoietic stem cell transplantation

Evaluation of pharmaceutical intervention in direct-acting antiviral agents for hepatitis C virus infected patients in an ambulatory setting: a retrospective analysis

Evaluation of the usefulness of protocol-based pharmacist-facilitated laboratory monitoring to ensure the safety of immune checkpoint inhibitors in patients with lung cancer

Implementation of institutional antiemetic guidelines for low emetic risk chemotherapy with docetaxel: a clinical and cost evaluation.

Incidence and risk factors for paclitaxel hypersensitivity during ovarian cancer chemotherapy.

Increased Topical Tacrolimus Absorption in Generalized Leukemic Erythroderma ⬇️

Interaction between warfarin and short-term intravenous amiodarone in intensive care unit patients after cardiac surgery.

Involvement of spinal NR2B-containing NMDA receptors in oxaliplatin-induced mechanical allodynia in rats.

Monitoring for potential adverse drug reactions in patients receiving chemotherapy.

Ovariectomy aggravates hypersensitivity reactions to paclitaxel in rats

Population pharmacokinetics of tacrolimus in umbilical cord blood transplant patients focusing on the variation in red blood cell counts

Prevention of oxaliplatin‐induced mechanical allodynia and neurodegeneration by neurotropin in the rat model ⬇️

Risk Factors for Major Bleeding and Clinically Relevant Non-major Bleeding in Japanese Patients Treated with Edoxaban

Risk Factors for Predicting Severe Neutropenia Induced by Pemetrexed Plus Carboplatin Therapy in Patients with Advanced Non-small Cell Lung Cancer

Risk factors for predicting severe neutropenia induced by amrubicin in patients with advanced lung cancer.

Stability of cetuximab and panitumumab in glass vials and polyvinyl chloride bags.

Switching from zoledronic acid to denosumab increases the risk for developing medication-related osteonecrosis of the jaw in patients with bone metastases

Time Course of Calcium Concentrations and Risk Factors for Hypocalcemia in Patients Receiving Denosumab for the Treatment of Bone Metastases From Cancer